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Abstract
Background: Patient take-up and adherence to antidepressants and talking therapy is low. However, 
little is known about how GPs recommend these treatments and whether patients accept them.
Aim: To examine how GPs recommend antidepressants and talking therapy, and how patients respond.
Design & setting: A total of 52 recorded primary care consultations for depression, anxiety, and stress 
were analysed.
Method: Using a standardised coding scheme, five ways doctors recommend treatment were coded, 
conveying varying authority and endorsement. The treatment recommendation types were as follows: 
more directive pronouncements (I’ll start you on X); proposals (How about we start X?); less directive 
suggestions (Would you like to try X?); offers (Do you want me to give you X?); and assertions (There 
are medications that might help). It was also coded whether patients accepted, passively resisted (for 
example, withholding response), or actively resisted (for example, I’ve tried that before).
Results: A total of 33 recommendations occurred in 23 consultations. In two-thirds of cases, GPs 
treated the patient as primary decision-maker by using suggestions, offers, or assertions. In one-
third of cases, they used more directive pronouncements or proposals. GPs endorsed treatment 
moderately (67%), weakly (18%), or strongly (15%). Only one-quarter of recommendations were 
accepted immediately. Patients cited fears about medication side effects and/or dependency, group 
therapy, and doubts about treatment efficacy. Despite three-quarters of patients resisting, 76% got 
prescriptions or self-referral information for talking therapy.
Conclusion: Initially, GPs treat patients as the decision-maker. However, although patients resist, 
most end up with treatment. This may impact negatively on treatment uptake and success. Social 
prescribing may fill a treatment gap for some patients.
How this fits in
Research has indicated low patient adherence for antidepressants and low uptake rates for 
counselling. Using a standardised coding scheme to analyse how GPs recommend treatment and 
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how patients respond in recorded real-life consultations, this article shows that GPs overwhelmingly 
leave decisions about these treatments to patients. It also suggests that patients frequently resist such 
recommendations, sometimes explaining their reasons for doing so (concerns about dependence, 
efficacy, and so on). Patients who resisted typically ended up being given the treatments anyway. 
Analysis of cases where patients resist suggests discussing and providing information about treatment 
options before making a recommendation could improve patient acceptance and uptake.
Introduction
Mental health conditions account for a significant proportion of primary care consultations: around 
one-third of GP visits in the UK are prompted wholly or partially by mental health concerns.1 The 
National Institute for Health and Care Excellence (NICE) guidelines for the treatment of common 
mental health disorders (depression and anxiety) recommend antidepressants and talking therapy, 
either separately or in combination for more severe cases.2 In 2016, 64.7 million prescriptions for 
antidepressants were issued in England, which was a 108.5% increase since 2006.3,4 However, despite 
this accumulation, most new courses of antidepressants are not completed.5 In 2017–2018, there were 
also 1.44 million new talking therapy referrals, which is a 3.9% increase on 2016–2017.6
There has been intense debate about the efficacy of antidepressants for mild to moderate 
depression,7,8 and there is a range of views within the profession on whether antidepressants are 
being under- or overprescribed.9,10 There are similar questions about the efficacy of antidepressants 
for anxiety disorders.11 These issues are of practical relevance to GPs, who may wish to offer patients 
the hope that comes with offering treatment while also having doubts as to the efficacy of that 
treatment.12
People diagnosed with depression and anxiety also express wide-ranging views and preferences 
on the benefits and problems associated with antidepressant use.13–15 After being prescribed 
antidepressants, less than one-fifth of patients took antidepressants in line with clinical guidelines over 
6 months.5 Moreover, 31% of talking therapy referrals ended before treatment began.6 Despite the 
controversial nature of antidepressant treatment in primary care, little is known about how decisions 
to start antidepressants and initiate patient referral to talking therapy are negotiated and endorsed 
in GP–patient consultations.
Doctor–patient communication about treatment beyond mental health has been the focus 
of recent research in primary16 and secondary17,18 care. By analysing recordings of doctor–patient 
communication, this work has shed light on who is driving treatment decisions: of particular interest 
here is how strongly the doctor recommends the treatment; whether the GP or the patient is the primary 
decision-maker; and how positively the patient responds to the possibility of starting treatment.
These issues are reflected in subtle differences in how GPs formulate the recommendation; for 
example, ‘I’m going to start you on an antidepressant’ versus ‘Would you be interested in taking 
an antidepressant?’ and whether patients actively accept or resist the recommendation. These 
formulations range from highly directive, where the doctor makes the decision without soliciting the 
patient’s input, to non-directive, where the doctor leaves the decision to the patient.16 Interestingly, 
they also appear to reflect the doctor’s perspective on the perceived clinical benefit for the patient 
through stronger or weaker endorsement of the treatment.16
Similarly, subtle differences in how patients respond to treatment recommendations reflect 
acceptance or resistance and hence their stance on starting the treatment in question. A number 
of studies on acceptance and resistance in interaction have shown that acceptance occurs quickly 
and positively. Meanwhile, resistance can be passive or active: passive resistance involves a delayed 
response, a withheld response, a minimal verbal response (for example, mhm) or non-verbal response 
(a nod). Active resistance includes statements such as ‘I don’t want to take any medication’ or 
questioning the recommendation.19–21
Understanding how GPs and patients negotiate antidepressants and talking therapy on an 
interactional level offers a detailed view of what actually happens in practice. This can shed light on 
patient response to starting treatment in the consultation and also the wider social debate about 
treatment for depression. Hence, the aims of this study were to analyse how GPs recommend and 
endorse antidepressants and talking therapy in routine consultations in primary care, and whether 
patients accept or resist these recommendations.
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Method
Data and sampling
The data for this study were taken from the One in a Million archive22 of recorded primary consultations 
and analysed as part of a wider study (the DeStress project) on poverty and mental health.12 These 
recordings were collected from 23 GPs in 12 practices in the west of England between July 2014 and 
April 2015. Patients were approached before their appointments with participating GPs and, if they 
agreed to take part, their consultation was recorded. In total, 421 patients were approached, 21% (n 
= 87) of whom declined to participate in the study. Of the 334 who did consent to take part, seven 
recordings failed. See Jepson et al23 for further information on the One in a Million study.
Three hundred patients consented for their recording to be used in research. These 300 
consultations were screened for common mental health problems, that is, anxiety, depression, and 
stress (excluding conditions that were not mood related, such as psychosis and memory problems), 
using their International Classification of Primary Care, Second edition (ICPC-2) codes (see Appendix 
1 in supplementary materials for list). This left a total of 52 recordings for inclusion in this study, 48 of 
which were video, four of which were audio.
Treatment recommendations
The recordings were examined for sequences in which doctors recommended antidepressants or 
that the patient refer themselves to talking therapy. These two forms of treatment are different in 
that medication involves a decision that is made and acted on by the doctor within the consultation 
(that is, giving a prescription) while talking therapy requires the patient to take further action after the 
consultation by calling the number that the doctor has given them. For talking therapy, this is standard 
practice as psychology services advocate patients taking the step to make the initial call themselves.
Each sequence was then transcribed in detail to illustrate characteristics of speech such as pauses, 
overlap, stress, intonation, and pace using Jeffersonian conventions (see Appendix 2 for a glossary).24 
These characteristics, in particular pauses and overlap, are important in communicating acceptance of 
or resistance to a recommendation.
Each recommendation was coded using the Treatment Recommendation Coding Scheme,25 which 
was developed in US and UK primary care. This scheme codes for the first treatment recommendation 
in the data. While there may have been prior reference to treatment, this is the point at which a decision 
about treatment becomes relevant. The coding scheme considers both the type of recommendation 
that the GP uses and the level of endorsement, that is, how strongly they recommend the particular 
treatment. A small number of cases were coded in group sessions with the research term before the 
full body of cases was coded by two of the authors. Cohen’s kappa (κ) was used to calculate inter-rater 
reliability.
In accordance with the protocol, the GPs’ recommendations for antidepressants or talking therapy 
were coded as one of the five recommendation types:
1. Pronouncements — patients are given no choice; for example, ‘I will start you on medication.’.
2. Proposals — patients are invited to support or collaborate with the doctor’s idea; for example, 
‘How about we try medication?’.
3. Suggestions — patients are given the choice; for example, ‘Would you like to try medication?’.
4. Offers — doctors show a willingness to prescribe for the patient without actively supporting the 
treatment; for example, ‘Do you want me to give you medication?’.
5. Assertions — doctors state that treatment exists without suggesting it is good for the patient; 
for example, ‘There is a medication available.’.
The GP treatment recommendation was further categorised as: (1) doctor as decision-maker, that 
is pronouncements or proposals, which situate the doctor as the primary decision-maker; or (2) patient 
as decision-maker, that is, suggestions, offers, or assertions, which leave the patient to decide.
Doctor endorsement was also coded as weak (for example, ‘It would be worth reconsidering 
starting an antidepressant’), moderate (for example, ‘So maybe some talking therapy would be good’), 
or strong (for example, ‘I’m gonna give the you the contact details’) based on modal construction 
of the offer. Endorsement was based on the strength with which a GP used a particular type of 
recommendation. As noted above, endorsement may be a reflection of the GP’s perspective on the 
likely clinical benefit that the treatment has for the patient.
Ford J et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101670
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01  Doc: But there’s more .hhhh the- y’know so the- I’m gonna give
02        you a contact detail for something called [service]?
03        [Which i:s     ] (0.5) (eh eh) it’s- it’s: psychological=
04  Pat:  [((Nods)) Okay. ]
05  Doc: therapies.=So [  talk]ing therapies.
06  Pat:         [Okay. ]
Box 2  [case 32: 13:17/18:34]
Patient responses
The patient response was coded as: (1) acceptance: quick positive acceptance, for example, ‘I’d 
like to have that’; or (2) resistance: passive resistance was indicated by a minimal verbal or non-
verbal acknowledgement, for example, ‘mhm’, nodding, or no response; or active resistance was 
indicated by, for example, questioning the purpose of medication or indicating a wish not to take the 
medication; for example, ‘I’m not very keen, I don’t want to take more tablets.’
Results
In total, there were 33 treatment recommendations involving 13 GPs across 23 consultations. Of 
these consultations, 16 were with female patients, and seven were with male patients. At the time 
of the consultation, 14 of these patients were already receiving some form of treatment so the 
recommendation was either for an additional form of treatment or an adjustment to existing treatment. 
The mean patient age was 46 years (standard deviation [SD] 18, range 19–84 years). The shortest 
consultation was 7:13 minutes, and the longest consultation was 25:51 minutes (mean duration 15:28 
minutes, SD 0.21). Of the recommendations, nine were recommendations to start medication (27%), 
five to review an existing medication (15%), and 19 to start talking therapy (58%).
How do doctors recommend and endorse antidepressants and talking 
therapy to patients?
Almost two-thirds (60%) of GPs’ recommendations treated the patient as the primary decision-maker: 
18% using suggestions, 24% using offers, and 18% using assertions. In only 39% of cases did GPs 
deliver their recommendations in a way that treated the GP as the primary decision-maker: 15% using 
pronouncements, and 24% using proposals. Cohen’s kappa suggested strong agreement between 
coders (κ = 0.959, P<0.001).
Patient as decision-maker
An example of how GPs position the patient as the decision-maker can be seen in Box 1, lines 1 
and 3: the GP suggests that the patient consider talking therapy: 'So maybe some cognitive 
behavioural therapy would be good?' This marks this as their opinion while leaving open the 
possibility that the patient may have their own ideas about the best course of action. The patient 
accepts and does indeed leave the consultation with information about cognitive behavioural 
therapy. As above, the transcripts are all presented using the Jeffersonian24 transcription conventions. 
 
01   Doc: M::m. Yeah. .thhh [S- Yea:h. so may:be: some] cognitive=
02   Pat:                 [(                       )]
03   Doc: =behavioural therapy: [would be go]od. Because tha- you
04   Pat:                       [Yea:h.      ]
05   Doc: hav- (0.3) you haven’t had that befor:[e and it’s] a slightly=
06   Pat:                                 [No.     ]
07   Doc: =approach.
Box 1  [case 14: 09:17]
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Doctor as decision-maker
By comparison, in Box 2 the GP, at lines 1–2, uses a directive pronouncement: 'I’m gonna give you 
a contact detail for something called [talking therapy service].' The decision has already been made 
without eliciting the patient’s perspective on this course of action. As can be seen in line 3, there is 
no opportunity for the patient to respond and display their perspective on this course of action. They 
respond minimally, in overlap with the GP. They subsequently leaves the consultation with information 
about therapy ( see Box 3 for additional examples of each treatment recommendation type.)
Levels of endorsement
In line with their non-directive approach, GPs rarely offered strong endorsement for medication or 
talking therapy. The most common level of GP endorsement was moderate (67%), followed by weak 
(18%), and then strong (15%). Cohen’s kappa suggested strong agreement between coders (κ = 
1.000, P<0.001).
An example of weak endorsement can be seen in Box 3, example 2: ‘It would be worth considering 
restarting an antidepressant.’ The key features marking this as weak are the modal construction ‘it 
would be’ and the suggestion that the patient considers restarting an antidepressant. An example of 
moderate endorsement, meanwhile, can be seen in Box 3: ‘So maybe some talking therapy would 
be good.’ Here, the doctor again uses a modal construction ‘would be good’; although without 
the additional mitigating features that made the previous example weak. An example of strong 
endorsement, finally, can be seen in Box 2 ‘I’m gonna give you a contact detail for something called 
[Service].’ What makes this a strong endorsement is that the GP states, unconditionally and without 
mitigation, what they are ‘going’ to do.
How do patients respond to these recommendations?
acceptance
Patients initially accepted GPs’ recommendations in only one-quarter (24%) of cases. Examples of two 
such cases can be seen in Box 1 and Box 2: ‘Yeah’ (line 4); and ‘Okay’ (line 4). The patients in these 
examples make it clear that they are agreeing to the treatments that their GPs are recommending. 
They do so, furthermore, without delay (and, in Box 1, in overlap with the recommendation itself).
Resistance
In almost three-quarters (67%) of cases, patients resisted treatment recommendations, either passively 
(73%) or actively (27%). When actively resisting, patients expressed: a general aversion to medication 
(see Box 4); fears about dependency on medication; concerns about attending a group session (for 
therapy); and doubts about the efficacy of treatment (see Box 5). In 67% of the active resistance cases, 
the patient’s concern was addressed quickly, either by abandoning the recommendation entirely (50%) 
or addressing the concern (33%). In 17% of cases, however, the patient continued to express concern 
even after the doctor’s initial attempts to address it, leading to extended, 4-minute-long negotiation 
sequences (see, for example, Box 5). Cohen’s kappa suggested strong agreement between coders (κ 
= 0.758, P<0.001).
In Box 4, the patient actively resists medication. They starts out noting that they have previously 
taken a stoical stance towards a stomach condition but that this has become ‘harder’ recently. In 
response to this, the GP recommends medication at lines 10–11 with a proposal (that is, a doctor’s 
idea for the patient to endorse): ‘D’you think it might be a good idea to try something to pick you up 
a bit with your mood.’ In line 12, there is a long 2.2 second delay. The patient then responds (lines 
13–14, 16–17) with a disagreement marker ‘well’, followed by an account for why they would not like 
to take medication (they are ‘not one to take a load of tablets’, displaying a stoical stance) and partial 
agreement or partial disagreement, all of which mark resistance in conversation.
Indeed, the GP interprets the patient’s response as resistance. In response, the GP abandons 
this recommendation and proposes an alternative form of treatment (line 20): ‘Or maybe a bit of 
counselling.’
However, patient resistance did not always lead to the doctor abandoning their recommendation: 
in 76% of the cases where patients initially resisted GPs’ recommendations, they were ultimately 
given an antidepressant prescription, details for accessing talking therapy, or agreed to the doctor’s 
Ford J et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101670
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Example 1: Pronouncement
In this consultation, the patient wishes to restart their antidepressants, having tried unsuccessfully to wean themselves off them. In the course of 
talking about this, the GP also takes the opportunity to recommend talking treatment.
01  Doc:   If you fee:l they’re not worki:ng or: .hh u::m y’know things are
02     getting worse then obviously come back and we [can- we] can=
03  Pat:                          [Yea:h.  ]
04  Doc:   =think about what else to do, [.hhhh] U::m: and I’ll give you=
05  Pat:                 [Okay.]
06  Doc:   =the number for ((ser[vice)), .hhh A:n:d see what they say,=
07  Pat:              [(((Nods))
08  Doc:   =[And if that] doesn’t wo:rk but you want (.) private
09  Pat:    [M::m:.    ]
10  Doc:   =counselli:ng then u:m pt. .hhh there’s: a (0.4) g- a s- u::h
11     service called ((Name)) Serv[ice? .hhh    ] And they have=
12  Pat:               [Oh ri:ght. Yea:h. ]
13  Doc:   =a l:i:st of all the accredited (.) the:rapists: in the area,
Example 2: Suggestion
In this consultation, the patient has recently stopped their antidepressants. Their mood has worsened as a result, and they have come to the GP 
about this. As the extract begins, the GP is raising the possibility of restarting an antidepressant.
01  Doc:   Also: .hhhh u::m give:n (0.5) th- all your symptoms:: it sounds
02     like that y’know that: you::r depression has quite- has really
03     dipped. N’okay¿ .hhh (.) You’re now not taking any (.) you’ve
04     taken yourself off the citalopram and that’s been some
05     time.=It’s been July:. .hhh so:: it:: (0.7) (eh) and (eh) (0.4)
06     it would be: (ww)worth considering restarting an antidepressant.
07     .hhh Maybe an alternative antidepress- You could go back on
08     Citalopram, Okay¿ Which will help with the anxiety and will help
09     with the depression,=And you did tolerate it well in the
10     past.=That’s grea- You didn’t have side effects on it.
11     [.hhhh] No. That would be one option.
12  Pat:   [No.  ]
Example 3: Proposal
In this consultation, the patient has recently started antidepressants. While these have had some benefit, they have also had various side effects. 
The extract begins as the GP is recommending that the patient stay on their current dose for the time being.
01  Doc:   BUT U::M for some rea:so:n we find that fifteen miligra:ms
02     .hhh at night ti:me .hhh when (we started it) can be quite
03     sedating at night time [but it ] helps people with sleep.=
04  Pat:            [Right.]
06  Doc:   =.hhhh I would propose (0.3) (eh) (0.3) NOT to increa- because
07     you’ve only been on it (y’know) [just   ] under two weeks okay.
08  Pat:                 [Okay.]
09  Doc:   .hhh To continue a:s is for another two weeks, [I’ll    ] review=
10  Pat:                        [Yeah.]
11  Doc:   =you in two weeks’ time,
Example 4: Offer 
In this consultation, the patient has experienced a flare-up of their bulimia, having recently moved to the UK to study. The GP has recommended 
various courses of action that they can take and, as the extract begins, is recommending a psychological service for people with eating disorders.
01  Doc:   And the other thing that might be helpful is that we have (0.4)
02     u:m an eating disorders servi:ce called ((Service)), U::m pt. .hh
03     which is tck. for people- mainly for people with bulimia
04     actuall[y:,   ] Um and I could refer you to them,
05  Pat:     [Yea:h.] I would really
06     app[reciate that.]
07  Doc:   [    U::m] and they would (.) they would see: you for
08     <psychological input> side of things.
Example 5: Assertion
In this consultation, the patient suffers from various physical health issues (about which they have spoken to the GP before) that have, in turn, 
impacted on their mental health (about which they have not spoken to the GP before). As the extract begins, the GP is describing the treatments 
that are available for depression.
01  Doc:   I mean I think in- in broad ter:ms I would say there are
02     three things that are- are (.) are- are quite helpful in
03     depression. Okay. .hhh Um .hh (0.4) one of them is- is (.)
04     counselling,
05     (0.3)
06  Pat:   ((Nodding)) Ye[ah.]
07  Doc:           [Whi]ch comes in different sor:ts and
08     flavours, Okay.
Box 3  examples of treatment recommendations and responses
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01  Pat:   And I tri:es to put a brave face on it ↑don't ↑↑I.
02  Com:  Yeah.
03      (0.4)
04  Com:  (Yeah/You) try to keep going but (0.6)
05  Pat:   .shih
06      (0.6)
07  Pat:   It gets HARd~e::r.~
08  Com:  it's getting increasingly difficult.
09       (1.8)
10  Doc:  D’you think it might be a good idea: to have somethi:ng to pick
11      you u:p a bi:t with your moo:d.
12      (2.2)
13  Pat:   Well I could t- sh- (.) try something.=I mean I'm not one to
14      take a loada tablets anyway ( ) [but__  ] .hhh=
15  Doc:                 [Mm-hm.]
16  Pat:   =could have somethi:ng to hhhh (0.6) .hhh ↑to pick me up I↑
17      ↑s’po:s::e.
18      (0.9)
19  Pat:   .shih
20  Doc:  Or maybe a bit of counselli:ng.
21      ((Patient sniffling)) (2.7)
22  Doc:  ‘Cos you've bee:n through a lo:t haven't you¿
23      (1.8)
Box 4  [case 17: 14:09/21:39]
recommendations to adjust the patient’s medication dosage. Box  5 shows an example of a case 
where the patient goes from resisting to ultimately accepting the treatment.
Box 5 begins as the GP is recommending talking therapy for the patient’s long-term mental health 
issues. Previously in the consultation, the patient has stated that they do not want talking therapy or 
medication.
The GP’s treatment recommendation at lines 06–07 is a proposal with moderate endorsement: 
‘What about trying something to try and make your mood a bit better.’ Following this, at line 08, 
there is a 1.2 second silence and no response from the patient. This delay and lack of patient uptake 
displays passive resistance.
There follows a discussion about the patient’s physical health, after which the GP in line 12, 
reiterates their earlier treatment recommendation: ‘What if something like that actually did help?’ 
The patient passively resists again by not responding (lines 19 and 21). The patient then voices their 
resistance more actively at lines 22–23 (they don’t think it would help), which the GP responds to with 
an objection of their own at lines 24–25: ‘But how would you know if you haven’t tried it.’
In contrast to the previous example, the GP has continued to pursue their treatment recommendation 
after the patient has resisted. This continues for several more minutes, with the GP raising the 
matter again after checking the patient’s blood pressure at line 27: ‘So what are we going to do.’ 
The patient responds by praising the doctor as ‘wonderful’ (line 28) and referring to themselves in 
a self-deprecating way (lines 30 and 33). The doctor disregards the patient’s compliment (‘I’m not 
wonderful’, line 32) but reiterates that they would like the patient to ‘think about what [they have] 
said.’ This is a downgraded form of their earlier recommendation, that is, ‘thinking about’ counselling 
as opposed to ‘trying’ it, which the patient agrees to at lines 37 and 40: ‘I will.’
To summarise, the patient has gone from resisting a recommendation to agreeing to ‘think’ about 
it. This lays the groundwork for later in the consultation, where they do indeed agree to take the 
information about the counselling. This starts at lines 42–43, with the GP offering to give the patient 
the number for counselling. Following a 1.1 second gap at line 44, the GP clarifies that there is 
no commitment associated with taking the number. The GP then, after another unanswered appeal 
(‘Would you appease me? ... With taking the number?’), says that they are ‘gonna write it down’ for 
the patient at line 52. The patient thanks them for doing so (line 54) and leaves the consultation with 
the phone number.
During the consultation, this patient has gone from resisting a recommendation for counselling to 
ultimately accepting the information about it. This highlights both the lack of acceptability of the GP’s 
original treatment recommendation and the additional work that was needed to solicit the patient’s 
acceptance to think about counselling. Indeed, it is notable that, while this GP started out with a type of 
Ford J et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101670
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01  Doc:   Would you think about seei:ng the mental health
02     tea:m again.
03     (2.4)
04  Pat:   No::h. Well (0.6) no. Because I:: um (2.2) hh I can’t uh- I
05     don’t think it would help.
06  Doc:   What about trying something to (.) try: and make your
07     mood a bit better.
08     (1.2)
09  Pat:   I don’t really want any more- any medication either.
10     ((4 minutes, 45 seconds omitted--discussion about patient’s
11     physical health))
12  Doc:   But do you think maybe talking to someone about tha:t might- I
13     know it might be very very difficult, .hhh But y’know ((patient
14     name)) you could live for many many more years and you’re
15     obviously not happy as it is now, .hh Although y:-
16     (0.6) I can take on board that you’re not keen for
17     a medication or talking to someone what if (.)
18     something like tha:t actually did help?
19     (0.3)
20  Doc:   E:ven if it was difficult initially.
21     (2.0)
22  Pat:   pt. .hhh (0.3) I don’t really think it wou:ld. I
23     think um:: pt. [.hh ]
24  Doc:        [But] how would you kn(h)ow £if you haven’t tried
25     it.£
26     ((2 minutes, 30 seconds omitted))
27  Doc:   So what are we going to do::.
28  Pat:   ((Doctor’s name)) you’re wonderful.
29     (0.9)
30  Pat:   I’m sorry whoever’s listening to this rubbish.
31     (1.1)
32  Doc:   I’m [not wonder]ful,
33  Pat:     [(From) me. ]
34     (0.4)
35  Doc:   I d- I- (.) But I d- I do w- (m-) I want you to
36     [think about] what I’ve said.
37  Pat:   [hhhh    ]     Yes. I [will.]
38  Doc:                [ Ab]out maybe
39     talking to someone.
40  Pat:   I will.
41     ((1 minute, 10 seconds omitted))
42  Doc:   Can I give you the number for this counselling in case
43     you do think you want to give it a g#o.#
44     (1.1)
45  Doc:   You just have to ring them you’re not committing to
46     anyth#ing.#
47     (2.8)
48  Doc:   Would you appease me?
49     (0.7)
50  Doc:   With taking the number?
51     (1.0)
52  Doc:   I’m gonna write it down for you.
53     (0.6) ((Doc begins writing))
54  Pat:   (Alººright.ºº/Oh.) Thank you.
Box 5  [case 01: 04:07/18:07]
recommendation that treated the patient as the primary decision-maker (a suggestion), they ultimately 
ended up using a type that situates themselves as the primary decision-maker (a pronouncement). It is 
also notable that their final appeal was based on their relationship with the patient (‘will you appease 
me?’) rather than the benefit that the treatment is likely to have. This indicates the delicate balance 
between facilitating patient autonomy, and GPs’ beliefs and interactional work to persuade patients 
to try talking therapy, if they believe this may benefit patients in the longer term,
A crosstabulation of acceptance and resistance by treatment type can be seen in Table  1. 
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Table 1 Cross-tabulation of treatment type, 
treatment recommendation, and patient re-
sponse
Treatment type
Patient response
TotalAccepts Resists
Medication (start) 2 7 9
Medication (adjust) 3 2 5
Talking treatment (start) 3 16 19
Total 8 25 33
Discussion
Summary
This micro-analysis of communication in primary 
care consultations shows that GPs overwhelmingly 
position the patient as the primary decision-
maker when raising the possibility of starting 
antidepressants or talking therapy, and tend not 
to strongly endorse either treatment. Through the 
subtle ways in which they raise treatments, they 
mark the patient as decision-maker (suggestions, 
offers, and assertions) two-thirds of the time, 
and doctor as decision-maker (pronouncements 
and proposals) only one-third of the time. Meanwhile, patients tended to resist rather than accept 
antidepressants and talking therapy. Patients accepted treatment in only one-quarter of cases. They 
initially resisted treatment — passively or actively — in three-quarters of cases. Patients resisted 
treatment because of doubts about the efficacy of treatment based on previous experiences, fears 
about dependency and/or side effects, and concerns about attending group therapy. Despite patient 
resistance, 76% left the consultation with medication or information to self-refer to talking therapy.
It was noted above that, while GPs may wish to give patients hope for a treatment, this can be 
complicated by concerns about being too directive and, sometimes, their own doubts about the 
efficacy of treatment.12 The findings here support this, suggesting that, to a large degree, GPs offer 
only moderate endorsement of treatments and communicated with patients with common mental 
health problems as collaborative partners in the decision-making process. On a speculative note, 
it would be worth exploring in future studies whether low endorsement may engender resistance: 
if GPs do not convey strong support for a treatment, this may make patients more likely to reject 
those treatments. It would also be worth exploring whether more openness about effectiveness and 
medication side effects26 (and withdrawal) might result in higher adherence (albeit with lower numbers 
of prescriptions) and more efficient use of GP time. This would require more time than is currently 
available in primary care consultations.
When patients do resist, GPs often pursue acceptance of treatment. Analysis of one such case 
showed that while the GP started with a recommendation that situated the patient as the primary 
decision-maker, they increased their own involvement in, and endorsement of, the decision to achieve 
the patient’s acceptance, also appealing to their relationship with the patient to persuade the patient 
to think about talking therapy. There was thus a tension between the GP positioning the patient as 
the decision-maker initially while taking a more active role when the patient, in that role, resisted. 
This may be related to the time pressure in brief primary care consultations, where GPs wish to offer 
patients some options to move forward. It also echoes GP perspectives on working with people with 
mental health problems to guide them towards different understandings and ways of managing their 
problems over the longer term (Parker et al, unpublished data, 2019a).
Strengths and limitations
The main strength of this study is that it used a standardised coding system25 that captures the subtle 
ways in which doctors recommend treatment and how patients respond. It has thus, for the first time, 
shed light on the process via which doctors and patients negotiate treatments for common mental 
health conditions. The use of a coding scheme does, however, to some extent involve decontextualising 
individual cases from the wider consultations in which they occurred. Hence, the nuances of individual 
cases could not be specifically analysed in this study.
A larger sample size would have enabled further comparisons between medication and talking 
therapy. Future research on this topic could use a more targeted form of data collection by sampling 
data on these criteria. It is also not known what patients did after leaving the consultation room. 
This means that in cases where patients were ultimately given information on self-referring to talking 
therapy, there is no way of knowing whether patients did indeed follow the GP’s recommendation.
Ford J et al. BJGP Open 2019; DOI: 10.3399/bjgpopen19X101670
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Comparison with existing literature
An earlier study on wider presenting problems in primary care using the same coding system16 
found pronouncements were most common, accounting for 29% of cases. In the current study, 
pronouncements accounted for only 15% of cases. Other treatment recommendation types were 
broadly similar across both studies, suggesting that GPs are less likely to use directive types when it 
comes to treatment for common mental health problems.
Another study27 using this coding system found that patients in England tend to display resistance 
to both prescription and non-prescription medication, evincing a general scepticism towards 
medications. This article both supports and extends these findings, suggesting patients in England 
are not only sceptical about antidepressant medication but also that this scepticism extends to talking 
therapy. The main reason for patients’ scepticism noted in the earlier study was perceived inefficacy 
of treatments, which was also found in the current study.
These findings are also in line with the wider literature on treatments for common mental health 
problems. Interview studies, for example, have shown that patients starting and taking antidepressants 
frequently express concerns about side effects and dependency,13–15 with one study suggesting that 
patients value being able to discuss such issues with their GP (Parker et al, unpublished data, 2019b). 
Such concerns are reflected in these findings, both in the high levels of resistance and the reasons 
patients cite for resistance to these treatments. These findings could also be linked to the high levels 
of non-adherence for both antidepressants5 and counselling.6
Implications for research and practice
When recommending mental health treatments, GPs overwhelmingly start by treating the patient 
as the primary decision-maker and do not strongly endorse available treatments. Although patients 
mostly resist treatment initially, most end up being given the treatment. If patients have not genuinely 
changed their mind, ongoing patient resistance is likely to lead to non-engagement in and lack of 
benefit from treatment. Awareness of, and discussion about, these concerns before making the 
recommendation could be of benefit to the patient and the doctor–patient relationship.
These findings suggest that the treatment options currently available in the UK, that is, medication 
and talking therapy, do not meet the needs of all patients. However, currently most GPs do not have 
other pathways or approaches to offer patients. Recognising that people’s health is determined by a 
range of social, economic, and environmental factors, there is increasing interest in addressing social 
causes of distress and social prescribing.28 Social prescribing involves GPs, nurses, and other primary 
care professionals referring people to a range of local, non-clinical services.
This could make a wider array of treatment options available for GPs to offer patients to address 
mental health problems.29 Currently, robust evidence on the effectiveness of social prescribing is 
limited, with most studies involving small-scale evaluations.28 The NHS Long-Term Plan specifically 
refers to more people benefiting from social prescribing and managing their health in partnership with 
the voluntary sector.30 However, availability of social prescribing is variable, largely beyond the GP’s 
control, and will need to be developed by policy-makers and local commissioners. Given patients’ 
resistance to existing treatment options, alternatives to medication and talking therapy that addresses 
social causes of distress could be more appealing for patients and GPs alike.
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